At Dynacare, our vision is to be Canada’s health and wellness solutions leader.
Effective January 10th, 2022, Dynacare will introduce changes to serum 17- hydroxyprogesterone and androstenedione testing. This testing will be performed using a laboratory developed test (LDT) which utilizes liquid chromatography with tandem mass spectrometry detection (LC-MS/MS) to replace the current immunoassay methods. This new LC-MS/MS assay will provide enhanced specificity and is considered the gold standard analytical technique for this testing.
Read More - Changes to Serum 17-Hydroxyprogesterone and Androstenedione Testing